NO20032471L - Farnesyltransferaseinhibitorer - Google Patents

Farnesyltransferaseinhibitorer

Info

Publication number
NO20032471L
NO20032471L NO20032471A NO20032471A NO20032471L NO 20032471 L NO20032471 L NO 20032471L NO 20032471 A NO20032471 A NO 20032471A NO 20032471 A NO20032471 A NO 20032471A NO 20032471 L NO20032471 L NO 20032471L
Authority
NO
Norway
Prior art keywords
farnesyl transferase
farnesyltransferase
inhibiting
thiazoles
patient
Prior art date
Application number
NO20032471A
Other languages
English (en)
Other versions
NO20032471D0 (no
Inventor
Akiyo K Claiborne
Ii Stephen L Gwaltney
Lisa A Hasvold
Qun Li
Tomgmei Li
Nan-Horng Lin
Robert A Mantei
Todd W Rockway
Hing L Sham
Gerard M Sullivan
Yunsong Tong
Gary T Wang
Le Wang
Xilu Wang
Weibo Wang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20032471D0 publication Critical patent/NO20032471D0/no
Publication of NO20032471L publication Critical patent/NO20032471L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Substituerte imidazoler og tiazoler med formel (I). er nyttige for å hemme farnesyltransferase. Også brakt for dagen er farnesyltransferase hemmende sammensetninger og fremgangsmåter for å hemme farnesyltransferase i en pasient.
NO20032471A 2000-11-30 2003-05-30 Farnesyltransferaseinhibitorer NO20032471L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72723000A 2000-11-30 2000-11-30
US09/912,677 US20020115640A1 (en) 2000-11-30 2001-07-25 Farnesyltransferase inhibitors
PCT/US2001/043168 WO2002074747A1 (en) 2000-11-30 2001-11-30 Farnesyltransferase inhibitors

Publications (2)

Publication Number Publication Date
NO20032471D0 NO20032471D0 (no) 2003-05-30
NO20032471L true NO20032471L (no) 2003-07-25

Family

ID=24921844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032471A NO20032471L (no) 2000-11-30 2003-05-30 Farnesyltransferaseinhibitorer

Country Status (30)

Country Link
US (1) US20020115640A1 (no)
EP (1) EP1339695B1 (no)
JP (1) JP2004519503A (no)
KR (1) KR20030060968A (no)
CN (1) CN1487924A (no)
AR (1) AR035375A1 (no)
AT (1) ATE323681T1 (no)
BG (1) BG107908A (no)
BR (1) BR0112028A (no)
CA (1) CA2430619A1 (no)
CY (1) CY1106104T1 (no)
CZ (1) CZ20031804A3 (no)
DE (1) DE60118955T2 (no)
DK (1) DK1339695T3 (no)
EC (1) ECSP034634A (no)
ES (1) ES2261340T3 (no)
HU (1) HUP0600331A2 (no)
IL (2) IL156212A0 (no)
MX (1) MXPA03004879A (no)
MY (1) MY136181A (no)
NO (1) NO20032471L (no)
NZ (1) NZ526313A (no)
PE (1) PE20020687A1 (no)
PL (1) PL363637A1 (no)
PT (1) PT1339695E (no)
SA (1) SA01220565B1 (no)
SI (1) SI1339695T1 (no)
SK (1) SK286686B6 (no)
UY (1) UY27046A1 (no)
WO (1) WO2002074747A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008539276A (ja) * 2005-04-27 2008-11-13 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド ヒト疾患に関連する変異体タンパク質の分解能を改善するための材料及び方法
JP4592548B2 (ja) * 2005-08-24 2010-12-01 株式会社エヌ・ティ・ティ・ドコモ 送信電力制御方法及び移動通信システム
US7722316B2 (en) * 2005-09-13 2010-05-25 Rolls-Royce Power Engineering Plc Acoustic viscous damper for centrifugal gas compressor
US7790770B2 (en) 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
US8084477B2 (en) * 2007-10-31 2011-12-27 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
US20110086834A1 (en) * 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2012069193A1 (de) * 2010-11-26 2012-05-31 Reza Ghotbi Implant zur behandlung oder prävention eines aneurysmas
CN105693617B (zh) * 2014-11-24 2018-06-08 中国科学院大连化学物理研究所 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法
EP3902100A1 (en) 2015-10-07 2021-10-27 Tc1 Llc Resonant power transfer systems having efficiency optimization based on receiver impedance
WO2018132791A1 (en) 2017-01-16 2018-07-19 The Regents Of The University Of California Treatment of neurodegenerative conditions by disruption of rhes
CN112851508B (zh) * 2019-11-27 2025-02-25 广东东阳光药业股份有限公司 一种巴洛沙韦中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891361A1 (en) * 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6297239B1 (en) * 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ATE289602T1 (de) * 1998-08-27 2005-03-15 Pfizer Prod Inc Quinolin-2-on-derivate verwendbar als antikrebsmittel

Also Published As

Publication number Publication date
AR035375A1 (es) 2004-05-12
CA2430619A1 (en) 2002-09-26
SI1339695T1 (sl) 2006-10-31
NZ526313A (en) 2004-11-26
SK8232003A3 (en) 2004-01-08
EP1339695A1 (en) 2003-09-03
ES2261340T3 (es) 2006-11-16
ECSP034634A (es) 2003-07-25
IL156212A (en) 2008-11-26
SA01220565B1 (ar) 2007-01-27
UY27046A1 (es) 2002-07-31
MY136181A (en) 2008-08-29
BR0112028A (pt) 2004-02-17
DE60118955T2 (de) 2007-01-04
CY1106104T1 (el) 2011-06-08
KR20030060968A (ko) 2003-07-16
BG107908A (bg) 2004-01-30
HK1059260A1 (en) 2004-06-25
NO20032471D0 (no) 2003-05-30
CN1487924A (zh) 2004-04-07
PE20020687A1 (es) 2002-08-03
WO2002074747A1 (en) 2002-09-26
ATE323681T1 (de) 2006-05-15
EP1339695B1 (en) 2006-04-19
DK1339695T3 (da) 2006-07-31
PL363637A1 (en) 2004-11-29
IL156212A0 (en) 2003-12-23
MXPA03004879A (es) 2004-05-04
CZ20031804A3 (cs) 2003-11-12
SK286686B6 (sk) 2009-03-05
PT1339695E (pt) 2006-08-31
DE60118955D1 (de) 2006-05-24
HUP0600331A2 (en) 2006-10-28
JP2004519503A (ja) 2004-07-02
US20020115640A1 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
BR0112965A (pt) Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-diona como inibidores de glocogênio sintase cinase-3beta
DE602004019548D1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
NO971537D0 (no) Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer for metalloproteaser
BR0014075A (pt) Inibidores de quinase como agentes terapêuticos
BR0307960A (pt) N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
PL377628A1 (pl) N3 Alkilowane pochodne benzoimidazolu, kompozycja je zawierająca oraz ich zastosowanie do wytwarzania leku do leczenia zaburzeń hiperproliferacyjnych
CY1114829T1 (el) Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις
NO20051339L (no) Anvendelse av lkB-kinaseinbibitorer ved behandling av smerte.
NO20060973L (no) Pyridylderivater og deres anvendelse som tempeutiske midler
DE502004007922D1 (de) Ketolactam-verbindungen und ihre verwendung
PL360886A1 (en) Non-imidazole aryloxyalkylamines
DE60042401D1 (de) Fab-i inhibitoren
GB0112348D0 (en) Compounds
ATE412657T1 (de) Therapeutische quinazolin-derivate
ATE380797T1 (de) Prenyl-transferase inhibitoren
TW200504019A (en) Diphenylpyridine derivatives, preparation thereof and application thereof in therapeutics
NO20015857D0 (no) Nye derivater og analoger av galantamin
MXPA03004879A (es) Inhibidores de farnesiltransferasa.
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
BRPI0408893A (pt) benzimidazóis cìclicos
DK1558580T3 (da) N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
PT1292290E (pt) Composicoes farmaceuticas que compreendem derivados de acriloil-distamicina e inibidores de topoisomerase 1 e ii
ATE299140T1 (de) Farnesyl-protein transferase inhibitoren
BR0113175A (pt) Derivados da quinolina como agentes antiinflamação

Legal Events

Date Code Title Description
ERR Erratum

Free format text: I PATENTTIDENDE NR. 36/05 BLE PATENTSOKNAD NR. 20032471 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING

Free format text: I PATENTTIDENDE NR. 36/05 BLE PATENTSOKNAD NR. 20032471 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING.

FC2A Withdrawal, rejection or dismissal of laid open patent application